Digoxin Use and Lower 30-Day All-Cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure

Eitemau Tebyg

• Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure
  gan: Bhatia, Vikas, et al.
  Cyhoeddwyd: (2014)
• Association of 30-day All-cause Readmission with Long-term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure
  gan: Arundel, Cherinne, et al.
  Cyhoeddwyd: (2016)
• Renin-Angiotensin System Inhibition and Lower 30-day All-cause Readmission in Medicare Beneficiaries with Heart Failure
  gan: Sanam, Kumar, et al.
  Cyhoeddwyd: (2016)
• Digoxin Reduces 30-Day All-Cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure
  gan: Bourge, Robert C., et al.
  Cyhoeddwyd: (2013)
• Lack of Evidence of Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone
  gan: Lam, Phillip H., et al.
  Cyhoeddwyd: (2016)